GFAP and Parkinson disease: And in MPTP-induced PD mice, hyperoside reverses the motor dysfunction, reduces pro-inflammatory factors production and down-regulates Iba-1 and GFAP via reducing NLRP3, ASC, and P20 expression and increasing PACAP content and CREB phosphorylation in the SN (63).